FEATURES
An interview with:
Professor
Valerie Beral
September 2005 |
 |
Professor
Valerie Beral talks about her research on breast
cancer, specifically her involvement with the Million
Women Study. The paper, "Breast cancer and
hormone replacement therapy in the Million Women
Study," (Million Women Study Collaborators, Lancet
362[9382]: 419-27, 9 August 2003), is ranked at #1
on our Special Topics list of papers published in the
past two years on breast cancer. At the time of our
analysis, the paper had 194 citations; it now has 327
cites. According to the ISI
Essential
Science Indicators
Web product, Professor Beral’s record includes 70
papers cited a total of 2,295 times to date in the
field of Clinical Medicine. Professor Beral is the
Director of the Epidemiology Unit at Cancer Research
UK in Oxford.
[read] |
|
An interview with:
Professor
Bruce Ponder
August 2005 |
|
In
this interview, Professor Bruce Ponder talks about his
highly cited work in breast cancer research. According
to our Special Topic on breast cancer, Professor
Ponder’s work ranks at #5, with 91 papers cited a
total of 7,665 times, and five of these papers
appearing in the top 20 list on our analysis. In the ISI
Essential
Science Indicators
Web product, Professor Ponder’s record includes 110
papers cited a total of 5,056 times to date in the
field of Clinical Medicine, and 34 papers cited a
total of 3,809 times to date in the field of Molecular
Biology & Genetics. Professor Ponder is a
Principal Investigator in the Department of Oncology
at the Hutchinson/MRC Research Centre in Cambridge,
England.
[read] |
|
|
An interview with:
Dr. Rowan Chlebowski
July 2005 |
|
Dr. Rowan Chlebowski discusses his paper,
"Influence of estrogen plus progestin on breast cancer
and mammography in healthy postmenopausal women—the Women’s
Health Initiative randomized trial," (Chlebowski, R.T.,
et al., JAMA-Journal of the American Medical Association,
289: 3243-53, 2003). This paper is ranked at #2 among papers
published in the past two years
in our Special Topic on breast cancer, and currently has 151
citations to its credit. In the ISI
Essential
Science Indicators
Web product, Dr. Chlebowski’s work can be found in the field
of Clinical Medicine and includes 33 papers cited a total of
1,315 times to date.
[read]
Dr. Bruce Ponder
|
|
|
An interview with:
Dr.
Steven Narod
June 2005 |
|
According
to our 2005 analysis of breast cancer research, Dr.
Steven Narod ranks as the most-cited author, with 193
papers cited a total of 11,624 times to date. He is a
co-author of the #1 paper on our list with 2,233
cites, "A strong candidate for the breast and
ovarian cancer susceptibility gene BRCA1," (Science
266: 66-71, 1994). In the ISI
Essential
Science Indicators
Web product, Dr. Narod’s work can be found in the
fields of Clinical Medicine and Molecular Biology
& Genetics. In this interview, Dr. Narod talks
with Special Topics correspondent Gary Taubes about
his highly cited work.
[read] |
|
|
An interview with:
Professor Jack Cuzick
May 2005 |
|
Professor
Jack Cuzick talks about his paper, "Overview of
the main outcomes in breast cancer prevention
trials," (Cuzick J., et al., Lancet 361:
296-300, 2003). According to our new analysis of
breast cancer research over the past decade, this
paper ranks among the top 10 papers published on the
topic in the past two years, with 74 citations to
date. In the ISI
Essential Science Indicators
Web product, Professor Cuzick’s record includes 79
papers cited a total of 3,339 times to date in the
field of Clinical Medicine.
[read] |
|
|
|
